Ophthalmology Education and CME

Select a Specialty

mededtalks-ophthalmology-drug-delivery-in-neovascular-retinal-disease
CME

Drug Delivery in Neovascular Retinal Disease

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 9/27/2020
Credit Type(s): CME | Credit: 0.25

In this MedEdTalks Micro-CE podcast, Rishi P. Singh, MD, and Nancy M. Holekamp, MD, discuss delivery systems for neovascular retinal diseases, with a particular focus on…

go to activity»
J106-HEA002
EXPERT VIDEOCME

Diabetic Retinopathy Curbside Consults: Using Safety and Efficacy Data to Guide Treatment of Non-proliferative Diabetic Retinopathy

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 9/12/2020
Credit Type(s): CME | Credit: 0.25

In this case-based video, Sophie J. Bakri, MD, and Nadia K. Waheed MD, MPH, discuss the utilization of safety and efficacy data to guide treatment decisions in the…

go to activity»
Ace the Case: A 5-Year-Old Girl Presents to the Office With Difficulty Walking
CMEABIM MOC

Ace the Case: A 5-Year-Old Girl Presents to the Office With Difficulty Walking

There is no commercial support for this activity.

Expiration Date: 9/15/2020
Credit Type(s): CME / ABIM MOC | Credit: 0.25

This educational activity will utilize a case study to discuss the management of a 5-year-old girl with difficulty walking….

go to activity»
Key Questions in nr-axSpA: Understanding, Recognizing, and Managing Patients With nr-axSpA

The term spondyloarthritis (SpA) encompasses a spectrum of related inflammatory conditions with a predominance of either axial or peripheral manifestations. The figure…

go to activity»
Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration

nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have…

go to activity»
Neovascular Age-related Macular Degeneration: Emerging Therapies with an EYE On Treatment Frequency
CME

Neovascular Age-related Macular Degeneration: Emerging Therapies With an EYE On Treatment Frequency

This activity is supported by an educational grant from Novartis Pharmaceuticals Corporation.

Expiration Date: 8/27/2020
Credit Type(s): CME | Credit: 1.25

The treatment of neovascular age-related macular degeneration (nAMD) has been revolutionized through the introduction of intravitreal anti–vascular endothelial growth…

go to activity»
Neovascular AMD: The Drier the Better or Just a Bit Wetter?
CME

Neovascular AMD: The Drier the Better or Just a Bit Wetter?

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 9/26/2020
Credit Type(s): CME | Credit: 0.5

The presence of retinal fluid, as measured by optical coherence tomography, guides decision-making for the treatment of patients with neovascular age-related macular…

go to activity»
Diabetic Retinopathy Curbside Consults: Individualizing Treatment for Patients With Diabetic Retinopathy
EXPERT VIDEOCME

Diabetic Retinopathy Curbside Consults: Individualizing Treatment for Patients With Diabetic Retinopathy

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 9/12/2020
Credit Type(s): CME | Credit: 0.25

In this case-based video, Sophie J. Bakri, MD, and Rishi P. Singh, MD, discuss individualizing treatment options for patients with diabetic retinopathy based on symptoms…

go to activity»
J194
CME

Neovascular Retinal Disease: Examining Emerging Trends in Treatment

This activity is supported by an educational grant from Genentech, Inc.

Expiration Date: 9/11/2020
Credit Type(s): CME | Credit: 0.75

The integration of intravitreal anti-vascular endothelial growth factor (anti-VEGF) therapy into management protocols for the treatment of neovascular retinal disease…

go to activity»
Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration

nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have…

go to activity»
Looking to the Horizon: Earlier Diagnosis and Advances in Treating Neovascular Age-Related Macular Degeneration

nAMD is an incurable disease and can lead to permanent vision loss. nAMD imposes a high burden on patients and eye care providers alike, as optimal visual outcomes have…

go to activity»
Transitioning Treatment in Diabetic Retinopathy
CME

Transitioning Treatment in Diabetic Retinopathy

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Expiration Date: 7/18/2020
Credit Type(s): CME | Credit: 0.75

Intravitreal therapy has rapidly evolved to become a mainstay of treatment for many retinal diseases, offering delayed or arrested disease progression and the…

go to activity»